OMCL analyst estimates
Omnicell (OMCL) analyst ratings, the average price target and its range, and every firm's latest call.
OMCL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jul 31, 2026 | Wells Fargo | Omnicell price target lowered to $50 from $55 at Wells Fargo | $50.00 |
| Jul 31, 2026 | KeyBanc | Omnicell price target lowered to $65 from $70 at KeyBanc | $65.00 |
| Apr 29, 2026 | Craig-Hallum | Omnicell price target raised to $55 from $53 at Craig-Hallum | $55.00 |
| Apr 28, 2026 | KeyBanc | Omnicell price target raised to $70 from $60 at KeyBanc | $70.00 |
| Mar 13, 2026 | UBS | Omnicell (OMCL) Reiterated at Buy by Benchmark After Investor, CEO Meet | $60.00 |
| Feb 6, 2026 | Piper Sandler | Omnicell price target lowered to $49 from $63 at Piper Sandler | $49.00 |
| Jan 16, 2026 | UBS | Omnicell (OMCL) PT Raised to $53 at BofA Securities | $53.00 |
| Jan 7, 2026 | KeyBanc | Omnicell upgraded to Overweight from Sector Weight at KeyBanc | $60.00 |
| Jan 5, 2026 | Wells Fargo | Omnicell price target raised to $52 from $43 at Wells Fargo | $52.00 |
| Aug 11, 2025 | Piper Sandler | Omnicell (OMCL) PT Lowered to $55 at Piper Sandler Despite Guide Raise | $55.00 |
| May 14, 2025 | Wells Fargo | Omnicell upgraded to Overweight from Equal Weight at Wells Fargo | $35.00 |
| Jan 13, 2025 | Wells Fargo | Omnicell price target lowered to $40 from $49 at Wells Fargo | $40.00 |
| Oct 31, 2024 | Barclays | Omnicell price target raised to $58 from $39 at Barclays | $58.00 |
| Aug 5, 2024 | Piper Sandler | Omnicell (OMCL) PT Raised to $61 at Piper Sandler | $61.00 |
| Aug 2, 2024 | Barclays | Barclays Upgrades Omnicell (OMCL) to Equalweight | $39.00 |
- 5 firms rate OMCL: 5 buy, 0 hold, 0 sell.
- The average price target is $57.50 from 2 analysts, from $50.00 to $65.00.
Updated 2026-11-02 23:58 UTC